Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy
about
Anti-androgenic effects of flavonols in prostate cancerSoy and Health Update: Evaluation of the Clinical and Epidemiologic LiteratureA multi-targeted approach to suppress tumor-promoting inflammationAssociation of urinary phytoestrogen concentrations with serum concentrations of prostate-specific antigen in the National Health and Nutrition Examination Survey.Genistein increases epidermal growth factor receptor signaling and promotes tumor progression in advanced human prostate cancerInhibition of cancer cell invasion and metastasis by genisteinThe role of soy in vegetarian dietsEffects of a high dose, aglycone-rich soy extract on prostate-specific antigen and serum isoflavone concentrations in men with localized prostate cancer.Phytotherapeutic interventions in the management of biochemically recurrent prostate cancer: a systematic review of randomised trials.Equol an isoflavonoid: potential for improved prostate health, in vitro and in vivo evidence.Lesson learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogs.Phytochemicals in cancer prevention and therapy: truth or dare?Estrogens and prostate cancer: etiology, mediators, prevention, and management.Epigenetic activities of flavonoids in the prevention and treatment of cancerIsoflavone pharmacokinetics and metabolism after consumption of a standardized soy and soy-almond bread in men with asymptomatic prostate cancer.Cytotoxicity and cell cycle arrest induced by andrographolide lead to programmed cell death of MDA-MB-231 breast cancer cell lineXeno-oestrogens and phyto-oestrogens are alternative ligands for the androgen receptor.Clinical development of novel proteasome inhibitors for cancer treatment.Perspectives on the role of isoflavones in prostate cancer.Perspectives for cancer prevention with natural compoundsSoy isoflavones in conjunction with radiation therapy in patients with prostate cancerHarnessing the fruits of nature for the development of multi-targeted cancer therapeutics.Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial.Plant-derived alternative treatments for the aging male: facts and myths.Soy isoflavones and prostate cancer: a review of molecular mechanisms.Treatment of men with rising prostate-specific antigen levels following radical prostatectomy.Risks and benefits of dietary isoflavones for cancer.Does equol production determine soy endocrine effects?Morphological and reproductive characterization in hyacinth bean, Lablab purpureus (L.) sweet germplasm with clinically proven nutraceutical and pharmaceutical traits for use as a medicinal food.Genistein inhibits human prostate cancer cell detachment, invasion, and metastasis.An updated review of dietary isoflavones: Nutrition, processing, bioavailability and impacts on human health.Phytochemicals Targeting Estrogen Receptors: Beneficial Rather Than Adverse Effects?Chemoprevention of prostate cancer: Natural compounds, antiandrogens, and antioxidants - In vivo evidenceA phase I trial of mushroom powder in patients with biochemically recurrent prostate cancer: Roles of cytokines and myeloid-derived suppressor cells for Agaricus bisporus-induced prostate-specific antigen responses.Soy, Soy Foods and Their Role in Vegetarian Diets.Beyond androgen deprivation: ancillary integrative strategies for targeting the androgen receptor addiction of prostate cancer.
P2860
Q26777700-09F367C8-8060-42BD-907A-89EC4131B5BFQ28071946-3F23F459-E6D9-4562-85C4-B909C813926AQ28393278-6D9647D4-19A9-41CA-A1B8-0D718FBF3E5BQ33862301-DA094783-44BF-48BD-9C5C-544C7C502D8FQ33908395-81603554-F28D-446F-A2E8-CC85ADB8DCA7Q34105995-BCA6B190-5586-4C19-A647-666ACD525301Q34247970-7EF424E1-D56D-4FB6-A487-D18DCF54C52CQ34357401-A8B072B8-DAB1-4E82-A08A-EF8BBB58F2C0Q34514927-A9D9011D-545A-4C0C-8FCC-B410A93B72C2Q34547064-279BFF80-8834-461B-AD0B-3BE1B80F0031Q34976272-42F036CE-39F7-42C1-867E-BC594AE0CC29Q35155749-4FFD3ED9-C458-4129-8509-CDA2F55A5BABQ35196710-3C8F8C5B-E45B-4414-B9F6-D6D0708F0E11Q35835175-BC5D1697-B72F-414F-B0DC-B31CDFA46E91Q36249043-9E2670C0-F4CA-4576-A269-66581EE59C15Q36804628-29E54A8D-F2C7-460B-83E7-F58B13F47161Q37084688-78BE62E3-7EBF-40AE-9D4E-BEC3A50C83C6Q37136598-E0A2FA88-B1AE-4C72-A0B3-30E742A660BEQ37207772-F93EEA42-3370-4E9D-BB3E-7750E8C8D046Q37212228-17745036-F2BB-4042-83A8-F84D25C99B20Q37376217-BBFDBB17-D6B3-4004-A0CE-7E3C98CDF4F5Q37442309-C1DA2802-80EF-4955-996A-BA7C49C75FC1Q37577822-867CCA96-3FB3-4BDA-9D31-BDD2A5EE0AC7Q37641962-6E1A8945-405A-44E5-9798-669A25990BA5Q37654590-0EDBC7CB-B393-49B6-9865-C0411C83D255Q37821906-CE292D0B-39B3-42EA-AB6E-88A59155FB04Q37857841-1DE62F54-6A70-42D7-A331-09A5D9901954Q37988309-B3CC5838-0D90-4EBE-84DB-421E61712EFFQ37995663-F5D77D46-23D6-447D-8E4A-7246B1CC69A2Q38215654-7C6D3BC4-595C-42E6-8A47-EDE25768450AQ38632579-BF0D7AAB-7022-469D-A3EA-126D44563889Q39402269-C2D3FFC6-5BA2-4A75-8900-3950C6FAFC43Q39924579-006F0090-7B56-4933-9947-37DEE1B8C77BQ46086114-6AB71D59-9B18-4E69-B48C-507687D261B8Q47230001-BC869CAD-E89A-4C0A-AB68-C3F9772B3FC2Q50455684-15F68D05-EDFA-4EA2-86D4-3AD51E99A3BD
P2860
Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Phase II trial of isoflavone i ...... r after previous local therapy
@ast
Phase II trial of isoflavone i ...... r after previous local therapy
@en
Phase II trial of isoflavone i ...... after previous local therapy.
@nl
type
label
Phase II trial of isoflavone i ...... r after previous local therapy
@ast
Phase II trial of isoflavone i ...... r after previous local therapy
@en
Phase II trial of isoflavone i ...... after previous local therapy.
@nl
prefLabel
Phase II trial of isoflavone i ...... r after previous local therapy
@ast
Phase II trial of isoflavone i ...... r after previous local therapy
@en
Phase II trial of isoflavone i ...... after previous local therapy.
@nl
P2093
P2860
P356
P1433
P1476
Phase II trial of isoflavone i ...... r after previous local therapy
@en
P2093
Charles J Rosser
John M Pendleton
Kathleen T Shiverick
Myron Chang
Satoshi Anai
Winston W Tan
P2860
P2888
P356
10.1186/1471-2407-8-132
P407
P577
2008-05-11T00:00:00Z
P5875
P6179
1000747139